Page last updated: 2024-10-28

go 6976 and Cardiac Hypertrophy

go 6976 has been researched along with Cardiac Hypertrophy in 2 studies

Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meredith, EL1
Ardayfio, O1
Beattie, K1
Dobler, MR1
Enyedy, I1
Gaul, C1
Hosagrahara, V1
Jewell, C1
Koch, K1
Lee, W1
Lehmann, H1
McKinsey, TA1
Miranda, K1
Pagratis, N1
Pancost, M1
Patnaik, A1
Phan, D1
Plato, C1
Qian, M1
Rajaraman, V1
Rao, C1
Rozhitskaya, O1
Ruppen, T1
Shi, J1
Siska, SJ1
Springer, C1
van Eis, M1
Vega, RB1
von Matt, A1
Yang, L1
Yoon, T1
Zhang, JH1
Zhu, N1
Monovich, LG1
Lim, JY1
Park, SJ1
Hwang, HY1
Park, EJ1
Nam, JH1
Kim, J1
Park, SI1

Other Studies

2 other studies available for go 6976 and Cardiac Hypertrophy

ArticleYear
Identification of orally available naphthyridine protein kinase D inhibitors.
    Journal of medicinal chemistry, 2010, Aug-12, Volume: 53, Issue:15

    Topics: Active Transport, Cell Nucleus; Administration, Oral; Aminopyridines; Animals; Antihypertensive Agen

2010
TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation.
    Journal of molecular and cellular cardiology, 2005, Volume: 39, Issue:4

    Topics: Activating Transcription Factor 2; Animals; Atrial Natriuretic Factor; Carbazoles; Cardiomegaly; Cyc

2005